نتائج البحث - "Macía Rivas, Lola"

1

دورية أكاديمية

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

المؤلفون: Jimenez-Fonseca, Paula, Foy, Victoria, Raby, Sophie, Macía Rivas, Lola, Arrazubi, Virginia, Mirallas Viñas, Oriol, Carmona-Bayonas, Alberto

المساهمون: Institut Català de la Salut, Jimenez-Fonseca P Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain. Foy V, Raby S Department of Medical Oncology, Christie Hospital, Manchester, UK. Carmona-Bayonas A Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain. Macía-Rivas L Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain. Arrazubi V Medical Oncology Department, Complejo Hospitalario de Navarra, IdiSNA (Navarra Institute for Health Research), Pamplona, Spain. Mirallas O Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Estómac - Càncer - Prognosi, Esòfag - Càncer - Prognosi, Medicaments antineoplàstics - Ús terapèutic, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Stomach Neoplasms, DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Esophageal Neoplasms, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias gástricas, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias del esófago, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión

وصف الملف: application/pdf

العلاقة: Therapeutic Advances in Medical Oncology;15; https://doi.org/10.1177/17588359231157641Test; Jimenez-Fonseca P, Foy V, Raby S, Carmona-Bayonas A, Macía-Rivas L, Arrazubi V, et al. The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy. Ther Adv Med Oncol. 2023 Mar 4;15:1–16.; https://hdl.handle.net/11351/9226Test

الإتاحة: https://doi.org/10.1177/17588359231157641Test
https://hdl.handle.net/11351/9226Test

View record in BASE

النص الكامل